Wyss Institute at Harvard University Founding Director Donald Ingber and Technology Development Fellow Kambez Benam explain how the integrated smoking device mimics normal cigarette smoke exposure and how it can impact research into the causes of COPD and into new biomarkers and therapeutics. 

Previous articleLexicon Acquires Rights to Pain Candidate Developed with BMS
Next articlePhotos to Discourage Smoking